Toggle light / dark theme

Get the latest international news and world events from around the world.

Log in for authorized contributors

Imaging tech promises deepest looks yet into living brain tissue at single-cell resolution

Both for research and medical purposes, researchers have spent decades pushing the limits of microscopy to produce ever deeper and sharper images of brain activity, not only in the cortex but also in regions underneath such as the hippocampus. In a new study, a team of MIT scientists and engineers demonstrates a new microscope system capable of peering exceptionally deep into brain tissues to detect the molecular activity of individual cells by using sound.

“The major advance here is to enable us to image deeper at single-cell resolution,” said neuroscientist Mriganka Sur, a corresponding author along with mechanical engineering Professor Peter So and principal research scientist Brian Anthony. Sur is the Paul and Lilah Newton Professor in The Picower Institute for Learning and Memory and the Department of Brain and Cognitive Sciences at MIT.

In the journal Light: Science and Applications, the team demonstrates that they could detect NAD℗H, a molecule tightly associated with cell metabolism in general, and electrical activity in neurons in particular, all the way through samples such as a 1.1 mm “cerebral organoid,” a 3D-mini -like tissue generated from human stem cells, and a 0.7 mm thick slice of mouse brain tissue.

A Paradigm Shift in Evolutionary Biology: The Extended Evolutionary Synthesis and the Role of Epigenetics

The field of evolutionary biology has a rich and complex history, marked by periods of consensus and significant theoretical shifts. The cornerstone of modern evolutionary thought for much of the 20th century was the Modern Synthesis (MS), a theoretical framework that integrated Darwin’s theory of natural selection with Mendelian genetics.

It provided a powerful and elegant explanation for how evolution occurs, emphasizing the gradual accumulation of genetic mutations and their differential survival in a population. However, in recent decades, a growing body of evidence has begun to challenge the sufficiency of the MS, leading to the development of a new, more comprehensive framework: the Extended Evolutionary Synthesis (EES).

Researchers uncover dozens of traits driven by maternal versus paternal genes

Researchers developed a high-accuracy method to infer whether genetic variants come from the mother or father without needing parental genomes, analysing 286,666 UK Biobank participants. They uncovered over 30 parent-of-origin effects on traits from growth and metabolism to diabetes, many showing opposite effects depending on parental source.

Stem Cell Therapy Offers Hope for Repairing Brain Damage in Newborns

Oxygen deprivation around birth can lead to brain damage in babies, with far-reaching consequences. A new stem cell treatment administered via nasal drops is showing promising results. In a safety study conducted at UMC Utrecht, called PASSIoN, ten newborns received this ‘intranasal stem cell therapy’ shortly after birth. Most of the children showed remarkably positive development: they started walking earlier on average than untreated children with comparable brain damage, had no motor impairments, and none developed epilepsy or visual problems. The study results were published today in the scientific journal Stroke.

All ten babies in the study had a perinatal stroke: a type of brain injury that occurs just before, during, or shortly after birth, damaging the developing brain. This kind of injury can lead to long-term neurological problems such as cerebral palsy (CP), a condition that affects movement due to early brain damage.

Replacing brain immune cells in mice slows neurodegeneration in Stanford Medicine study

By Krista Conger

The technique, which used genetically healthy donor cells, prolonged life and function in mice with a disease similar to Tay-Sachs. It may help with other neurodegenerative diseases like Alzheimer’s.

Liz Parrish: Why She Risked Everything on an Unproven Treatment

What would you do if medicine offered no answers?

Liz Parrish didn’t wait for FDA approval. She became the first person in the world to take multiple gene therapies, using her own body to test a future that medicine wasn’t ready for.

Since then, she’s taken 10 gene therapies, helped over 300 people treat conditions once considered untreatable, and challenged one of the biggest assumptions in healthcare:

👉 Should we treat aging the same way we treat disease?

In this talk, Liz shares how her personal decision created ripple effects across the world — and why gene therapy may be the first real step toward extending not just health span, but lifespan.

What you’ll hear:

James Dyson reveals the future of farming

How do you grow 2.5x more strawberries? James Dyson reveals how engineers designed and built a unique way to increase Dyson Farming’s strawberry output.

Strawberries available in the UK from:
@Ocado
@marksandspencer
@sainsburys

Discover more about Dyson Farming:
dysonfarming.com.
#Dyson #InsideDyson #DysonFarming

/* */